Skip to main content

Advertisement

Table 5 Highest absorbed doses (mGy/MBq) of 188Re-liposome in tumor lesions of patients (n = 12)

From: A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of 188Re-liposome in patients with metastatic tumors

Tumor site Absorbed dose (mGy/MBq)
Tumor in bone
 Pt. 1 0.28
 Pt. 3 0.25
 Pt. 4 0.12
Tumor in pelvis
 Pt. 2 0.16
Tumor in rectum  
 Pt. 2 0.14
Tumor in lung
 Pt. 3 0.39
 Pt. 4 0.29
 Pt. 8 0.65
 Pt. 9 0.33
 Pt. 10 0.21
 Pt. 11 0.32
 Pt. 13 0.61
 Pt. 14 1.04
Tumor in liver
 Pt. 3 0.86
 Pt. 7 0.86
 Pt. 8 0.90
 Pt. 12 1.70
Tumor in bladder
 Pt. 12 0.16
Tumor in NP  
 Pt. 14 0.15
  1. Pt. patient